Last update :
18/04/2024
Curarimimetic   Suxamethonium chloride  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Actirelax Argentina
Anectine Great Britain, Ireland, Mexico, Spain, United Arab Emirates, United States of America
Celocurin Sweden
Celocurine Belgium, France
Chlorsucillin Poland
Cholsuxinyl Egypt
Cloruro de succinilcolina Argentina
Cloruro de suxametonio Peru
Curacit Norway
Distensil Peru
Entubate India
Ethicoline Malaysia
Fosfitone Argentina, Venezuela
Lycitrope Greece
Lysthenon Austria, Germany, Romania, Saudi Arabia, Switzerland, United Arab Emirates
Midarine Italy, Saudi Arabia, Switzerland
Mioflex Portugal, Spain
Miokolin Iran
Myoplegine Belgium, Luxembourg
Myotenlis Italy
Pantolax Germany
Quelicin Colombia
Succi Argentina
Succinilcholina Argentina
Succinilcholina cloruro Peru
Succinolin Switzerland
Succinyl Luxembourg
Succinylcholine Canada, Germany, Iran
Succyl Iran
Sukolin Finland
Suxamethonium Australia, Great Britain, Iran, Ireland, Malaysia, New Zealand
Suxametonio cloruro Chile, Peru
Suxim Peru
Uxicolin Colombia, Mexico
Stability in solutions   Injection   Stability in solutions : Suxamethonium chloride     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass None 20 mg/ml 25°C
139 Day
2360

Glass None 50 mg/ml 22-26°C Not specified
17 Day
4274
Level of evidence B

Polypropylen Syringe NaCl 0,9% or Glucose 5% 20 mg/ml 25°C Protect from light
100 Day
667
Level of evidence B

Polypropylen Syringe NaCl 0,9% or Glucose 5% 20 mg/ml 40°C Protect from light
22 Day
667
Level of evidence B

Polypropylen Syringe NaCl 0,9% or Glucose 5% 20 mg/ml 5°C Protect from light
107 Day
667
Level of evidence B

Polypropylen Syringe None 20 mg/ml 25°C Light
45 Day
1755
Level of evidence B

Polypropylen Syringe None 20 mg/ml 4°C Protect from light
90 Day
1755
Level of evidence B


  Mentions Légales